Adverse Effects of Covid-19 Vaccines Among Iraqi People

Abstract

Background: Coronaviruses are noteworthy disease-causing agents in humans and animals. A new strain of this virus was detected in 2019 as the source of a pneumonia outbreak in Wuhan, a city in China. The virus, originally named 2019-nCoV, quickly escalated from an epidemic within China to a global pandemic. The World Health Organization labeled the disease as COVID-19 in February 2020, which was caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  Coronaviruses are a large family of viruses that also include pathogens like Middle East respiratory syndrome (MERS-CoV) and severe acute respiratory syndrome (SARS-CoV). Early data suggests that roughly 99% of COVID-19 cases present with mild symptoms, while the remaining cases are severe or critical. As of January 31, 2021, there have been a total of 103,286,991 reported cases worldwide, with 2,232,776 deaths. Vaccines have appeared as a crucial tool in preventing SARS-CoV-2 infection and are considered the most promising approach to curbing the pandemic. The first human clinical trials for COVID-19 vaccines began in March 2020, and several phase III trials have been completed or are nearing completion. 

Study design and sample collection: This is a cross-sectional study that was collected from different Iraqi province, the study was involved 125 persons. Data collection during September 2021. A web-based self-report survey was administered to vaccinated persons. The electronic survey was administered through Google Form software. The survey link was distributed electronically via different social media groups (Facebook, WhatsApp, and Telegram).

Result: The median age of persons who was taken the vaccine is 32 years old. The females were higher than males in getting the vaccine with (56%) women and (44%) for men. A 59.2% of people were administer Pfizer vaccine, 24% were administer AstraZeneca and only 16.8% of people were administer Sino pharm. About half of persons (67) had fever, headache and arthralgia were occur in (51) and (43) persons respectively and then followed by pain at the site of injection about (14) persons. more than half people (70) had been shown adverse effects within first 12 hours and about (39) people had been shown adverse effects after 12 hours, these adverse effect durations were from 24 hours to more than 3 days. most people about (84) had been administered acetaminophen while (24) people were taken non-steroidal anti-inflammatory drugs to relief these symptoms.